While this vaccine induced binding antibodies to gp41 and HIV gp120, CD4+ T-cell responses to HIV-1 Env, and tier 1A virus-neutralizing antibodies, it, too, failed to provide protection against HIV infection (10, 11). This evidence concerns the gene ERVW-1 and HIV infectious disease.